We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical Solutn | LSE:MLS | London | Ordinary Share | GB0009739649 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.72 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSBS TIDMNAS
RNS Number : 1827E
Source BioScience PLC
02 November 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 1. Identity of the issuer or the SOURCE BIOSCIENCE PLC underlying issuer of existing shares to which voting rights are attached: (ii) -------------------------------------- ---------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------- An acquisition or disposal of voting rights YES ----------------------------------------------------------------- ------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------- ------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ----------------------------------------------------------------- ------ An event changing the breakdown of voting rights ----------------------------------------------------------------- ------ Other (please specify): ----------------- ---------------------------------------------- ------ 3. Full name of person(s) subject to the notification obligation: Harwood Capital LLP (as investment (iii) adviser/manager) and North Atlantic Smaller Companies Investment Trust plc ------------------------------------ ------------------------------------- 4. Full name of shareholder(s) (if different from 3.): (iv) 1. NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC 2. ORYX INTERNATIONAL GROWTH FUND LIMITED ------------------------------------ ------------------------------------- 5. Date of the transaction and date 29 OCTOBER 2015 on which the threshold is crossed or reached: (v) ------------------------------------ ------------------------------------- 6. Date on which issuer notified: 30 OCTOBER 2015 ------------------------------------ ------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) Total Holding through 15% ------------------------------------ ------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------- ---------------------------- -------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights -------------- ------------- ------------- ------------- ------------------------ --------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------- ------------- ------------- ------------- --------- ---------- --------- HOLDER 1 1,500,000 1,500,000 2,750,000 2,750,000 0.79% HOLDER 2 50,000,000 50,000,000 50,000,000 50,000,000 14.32% -------------- ------------- ------------- ------------- ------------- --------- ---------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion rights that rights Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------- -------------- ----------------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 52,750,000 15.11% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------- Proxy Voting: -------------------------------------- 10. Name of the proxy holder: ------------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------ 13. Additional information: ------------------------------- -------------- 14. Contact name: Jane Muir ------------------------------- -------------- 15. Contact telephone number: 020 8819 6486 ------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGGAWGUPAGUP
(END) Dow Jones Newswires
November 02, 2015 05:38 ET (10:38 GMT)
1 Year Medical Solutions Chart |
1 Month Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions